세계의 복막투석 시장 : 치료 유형별, 제품 유형별, 최종사용자별, 지역별, 범위 및 예측

Global Peritoneal Dialysis Market Size and Forecast

Global Peritoneal Dialysis Market size was valued at USD 85.41 Billion in 2024 and is projected to reach USD 150.08 Billion by 2031 , growing at a CAGR of 7.30% from 2024 to 2031. Peritoneal Dialysis is a renal replacement therapy that utilizes the peritoneum, a membrane lining the abdominal cavity, as a natural filter to remove waste products and excess fluids from the bloodstream. This method involves the infusion of a sterile dialysis solution into the abdominal cavity, where it absorbs waste through the peritoneal membrane and is then drained out.

Widely used for patients with chronic kidney disease or those awaiting kidney transplantation, peritoneal dialysis offers the advantages of home-based treatment, improved quality of life, and flexibility in lifestyle.

The future of peritoneal dialysis looks promising, with advancements in technology and solutions aimed at enhancing patient outcomes, increasing the efficiency of fluid and solute removal, and reducing complications.

Global Peritoneal Dialysis Market Dynamics

The key market dynamics that are shaping the global peritoneal dialysis market include:

Key Market Drivers:

Rising Prevalence of Chronic Kidney Disease (CKD):

The increasing incidence of chronic kidney disease significantly drives the demand for dialysis treatments. According to the Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States are estimated to have CKD, with a significant proportion requiring dialysis.

Growing Aging Population:

The aging population is a critical factor in the expansion of the peritoneal dialysis market. The World Health Organization (WHO) projects that the global population aged 60 years and older will reach 2 billion by 2050, which is expected to increase the prevalence of kidney-related diseases and the need for dialysis options.

Shift Toward Home-Based Care:

There is a notable trend toward home-based dialysis solutions due to the convenience and autonomy they offer patients. According to a report from the United States Renal Data System (USRDS), as of 2020, approximately 8% of all dialysis patients in the U.S. were using peritoneal dialysis, reflecting a growing preference for home therapies.

Technological Advancements:

Innovations in peritoneal dialysis equipment and solutions are enhancing treatment efficiency and patient outcomes. The International Society for Peritoneal Dialysis reported that new automated systems and improved dialysis solutions have the potential to increase patient acceptance and satisfaction, driving market growth. In 2022, the peritoneal dialysis market was valued at $4.5 billion and is projected to grow at a compound annual growth rate (CAGR) of 6.5% through 2030.

Key Challenges:

Infection Risks: Peritoneal dialysis is associated with a higher risk of infections, particularly peritonitis, which can complicate treatment and lead to severe health issues. This risk can deter patients from choosing this modality over hemodialysis.

Patient Education and Training: Effective peritoneal dialysis requires proper patient education and training to ensure successful home-based treatment. Many patients may lack the necessary support or resources to learn the required techniques, which can affect compliance and outcomes.

Access and Affordability: Access to peritoneal dialysis can be limited in certain regions, particularly in low-income or rural areas. Additionally, high costs associated with equipment, supplies, and healthcare services can pose a barrier for patients seeking this treatment.

Psychosocial Factors: Psychological aspects such as anxiety, depression, and social isolation can impact patients' willingness to engage in home dialysis. Addressing these psychosocial challenges is essential for improving treatment adherence and quality of life.

Key Trends:

Integration of Digital Health Technologies: The incorporation of telehealth and remote monitoring technologies is enhancing patient management and follow-up care in peritoneal dialysis. These innovations allow for better adherence to treatment protocols and timely intervention, thereby improving patient outcomes.

Personalized Treatment Approaches: There is a growing trend toward personalized medicine in peritoneal dialysis, where treatment plans are tailored to individual patient needs. This includes adjusting dialysis solutions and schedules based on patient-specific parameters, which can improve efficacy and satisfaction.

Expansion of Patient Education Programs: Enhanced educational initiatives aimed at both patients and healthcare providers are becoming more common. These programs focus on training patients about peritoneal dialysis procedures, potential complications, and management strategies, leading to better compliance and outcomes.

Increased Research and Development: Ongoing research efforts to improve peritoneal dialysis solutions and equipment are being prioritized. Companies are investing in developing new biocompatible solutions and automated systems to enhance the efficiency and safety of peritoneal dialysis, with several promising products expected to enter the market in the coming years.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Peritoneal Dialysis Market Regional Analysis

Here is a more detailed regional analysis of the global peritoneal dialysis market:

North America:

North America is the dominant region in the global peritoneal dialysis market, accounting for a significant share due to advanced healthcare infrastructure and a well-established reimbursement framework. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 37 million adults in the United States are estimated to have CKD, with a substantial proportion requiring dialysis treatment, driving the demand for peritoneal dialysis.

The presence of key market players, such as Baxter International and Fresenius Medical Care, further strengthens North America's leading position in the peritoneal dialysis market. In 2023, the North American market for peritoneal dialysis was valued at approximately $1.2 billion, reflecting a robust growth trajectory fueled by technological advancements and increased patient education regarding home-based treatment options.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for peritoneal dialysis, driven by rapid urbanization, increasing healthcare awareness, and a rising prevalence of kidney diseases. According to the National Kidney Foundation, the prevalence of kidney disease in India is expected to reach 200 million by 2030, highlighting the urgent need for effective treatment solutions.

Technological advancements and collaborations between healthcare providers and manufacturers also fuel market growth in the Asia Pacific region. In 2023, the Asia Pacific peritoneal dialysis market was valued at approximately $600 million, and it is projected to grow at a compound annual growth rate (CAGR) of over 10% through the next five years.

Global Peritoneal Dialysis Market: Segmentation Analysis

The Global Peritoneal Dialysis Market is segmented on the basis of By Treatment Type, By Product Type, By End User, and By Geography.

Global Peritoneal Dialysis Market, By Treatment Type

• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Automated Peritoneal Dialysis (APD)

Based on Treatment Type, the Global Peritoneal Dialysis Market is segmented into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). Continuous Ambulatory Peritoneal Dialysis (CAPD) is the dominating segment due to its simplicity and the ability for patients to manage their treatments independently without the need for machines. However, Automated Peritoneal Dialysis (APD) is the fastest-growing segment, driven by advancements in technology and the increasing demand for more convenient and efficient treatment options.

Global Peritoneal Dialysis Market, By Product Type

• Peritoneal Dialysis Solution Device
• Peritoneal Dialysis Set
• Catheter

Based on Product Type, the Global Peritoneal Dialysis Market is segmented into Peritoneal Dialysis Solution Device, Peritoneal Dialysis Set and Catheter. The Peritoneal Dialysis Solution Device is the dominating segment due to its essential role in the dialysis process and the high demand for effective dialysis solutions. However, the Peritoneal Dialysis Set segment is the fastest-growing, driven by increasing adoption rates of home-based dialysis and advancements in technology that enhance user convenience and treatment efficacy.

Global Peritoneal Dialysis Market, By End User

• Home-based Dialysis
• Dialysis Center & Hospital-based Dialysis

Based on End User, the Global Peritoneal Dialysis Market is segmented into Home-based Dialysis and Dialysis Center & Hospital-based Dialysis. Home-based dialysis is the dominating segment due to its convenience and patient autonomy, allowing individuals to manage their treatment in the comfort of their homes. However, the fastest-growing segment is hospital-based dialysis, driven by advancements in technology, improved treatment options, and increasing awareness among healthcare providers about the benefits of in-center treatment for patients with complex medical needs.

Global Peritoneal Dialysis Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Peritoneal Dialysis Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global peritoneal dialysis market, accounting for a significant share due to advanced healthcare infrastructure and a well-established reimbursement framework. The Asia Pacific region is the fastest-growing market for peritoneal dialysis, driven by rapid urbanization, increasing healthcare awareness, and a rising prevalence of kidney diseases.

Key Players

• The "Global Peritoneal Dialysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
• Fresenius Medical Care, Baxter International Inc., NxStage Medical Inc., DaVita Inc., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Braun Melsungen AG, Minntech Corporation, Maruho Co., Ltd., Terumo Corporation, Fresenius Kabi, Bellco Medical LLC, Vascular Solutions, Inc., Medtronic plc, Quanta Dialysis Technologies Ltd., Dialysis Clinic, Inc., US Renal Care, FMC Corporation, Amicus Therapeutics, Inc.
• Our
• market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
• Global Peritoneal Dialysis Market: Recent Developments
• In August 2024 Baxter International revealed plans to expand its manufacturing facilities for peritoneal dialysis products in response to increasing global demand. The expansion will enhance the company's production capacity and improve supply chain efficiency, allowing for quicker distribution of their innovative dialysis solutions.
• In July 2024 Medtronic announced a collaboration with several digital health companies to integrate remote monitoring capabilities into its peritoneal dialysis devices. This partnership aims to enhance patient engagement and streamline treatment management through real-time data sharing between patients and healthcare providers.
• In June 2024 Terumo Corporation unveiled new research initiatives focused on developing advanced peritoneal dialysis products that utilize biocompatible materials.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PERITONEAL DIALYSIS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PERITONEAL DIALYSIS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL PERITONEAL DIALYSIS MARKET, BY TREATMENT TYPE

• 5.1 Overview
• 5.2 Continuous Ambulatory Peritoneal Dialysis (CAPD)
• 5.3 Automated Peritoneal Dialysis (APD)

6 GLOBAL PERITONEAL DIALYSIS MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Peritoneal Dialysis Solution
• 6.3 Device
• 6.4 Peritoneal Dialysis Set
• 6.5 Catheter
• 6.6 Others

7 GLOBAL PERITONEAL DIALYSIS MARKET, BY END-USER

• 7.1 Overview
• 7.2 Home-based Dialysis
• 7.3 Dialysis Center & Hospital-based Dialysis

8 GLOBAL PERITONEAL DIALYSIS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL PERITONEAL DIALYSIS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Baxter International Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Fresenius Medical Care
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 NxStage Medical Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 DaVita Inc.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Asahi Kasei Medical Co., Ltd.
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Nipro Corporation
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 B. Braun Melsungen AG
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Minntech Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Maruho Co., Ltd.
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Terumo Corporation
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research